---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-26-000005"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:26:08.825709+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Maravai Q4 revenue $49.9M, net loss $63M; guides 2026 revenue $200-210M

## Summary
- Q4 revenue $49.9M, net loss $(63.0)M, positive Adj EBITDA $0.5M (non-GAAP).
- Full year 2025 revenue $185.7M, net loss $(230.8)M, Adj EBITDA $(31.2)M.
- Introduces 2026 revenue guidance $200M-$210M and Adj EBITDA guidance $18M-$20M.
- CEO cites strong execution, exceeding revenue expectations, returning to positive Adj EBITDA.
- Organizational restructuring and operating cost reduction ahead of plan.

## SEC filing metadata
- accession: 0001823239-26-000005
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000005/0001823239-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000005/mrvi-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-26-000005
- JSON: https://secwatch.observer/filing/0001823239-26-000005.json
- Plain text: https://secwatch.observer/filing/0001823239-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.